Utah Medical Products, Inc.
UTMD
$57.80
$1.362.41%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 39.27M | 40.90M | 44.08M | 46.58M | 49.04M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 39.27M | 40.90M | 44.08M | 46.58M | 49.04M |
| Cost of Revenue | 16.36M | 16.76M | 18.16M | 19.10M | 20.08M |
| Gross Profit | 22.92M | 24.14M | 25.92M | 27.48M | 28.96M |
| SG&A Expenses | 7.65M | 7.60M | 8.01M | 9.08M | 10.06M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 24.71M | 25.17M | 27.01M | 28.99M | 30.82M |
| Operating Income | 14.56M | 15.73M | 17.07M | 17.59M | 18.22M |
| Income Before Tax | 15.86M | 16.80M | 18.21M | 18.81M | 19.77M |
| Income Tax Expenses | 2.90M | 2.93M | 2.95M | 3.18M | 3.39M |
| Earnings from Continuing Operations | 12.96 | 13.87 | 15.26 | 15.63 | 16.38 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 12.96M | 13.87M | 15.26M | 15.63M | 16.38M |
| EBIT | 14.56M | 15.73M | 17.07M | 17.59M | 18.22M |
| EBITDA | 17.40M | 18.53M | 20.17M | 21.74M | 23.46M |
| EPS Basic | 3.78 | 3.95 | 4.28 | 4.34 | 4.52 |
| Normalized Basic EPS | 3.20 | 3.37 | 3.62 | 3.67 | 3.75 |
| EPS Diluted | 3.77 | 3.95 | 4.27 | 4.33 | 4.50 |
| Normalized Diluted EPS | 3.20 | 3.37 | 3.62 | 3.67 | 3.75 |
| Average Basic Shares Outstanding | 13.71M | 14.02M | 14.26M | 14.41M | 14.51M |
| Average Diluted Shares Outstanding | 13.71M | 14.02M | 14.26M | 14.42M | 14.53M |
| Dividend Per Share | 1.21 | 1.21 | 1.20 | 1.20 | 1.19 |
| Payout Ratio | 32.32% | 30.70% | 28.14% | 27.59% | 26.26% |